By Dave Steger
David McAneny, MD, named councilor of the BU School of Medicine Chapter of Alpha Omega Alpha Honor Medical Society
David McAneny, MD, Associate Professor of Surgery, Boston University School of Medicine, has been named councilor of the BU School of Medicine Chapter of Alpha Omega Alpha Honor Medical Society (AOA).
A national honor society, AOA recognizes excellence in scholarship and supports high standards and ethics in the profession of medicine. Being elected to AOA identifies the member as committed to scholarship, leadership, professionalism and service. Along with the student officers, faculty councilors organize chapter functions, projects, meetings, and most importantly the annual selection of nominees for election to membership in AOA.
Boston Herald: Amid chaos of Marathon Monday, pedicab driver was just what the doctor ordered for BMC surgeon
BMC/BUSM vascular surgeon, Jeffrey Kalish, MD, was featured in a Boston Herald story about getting to campus on Marathon Monday. Click here to read the article.
Alik Farber, MD, was elected to distinguished fellow status of the Society for Vascular Surgery® (SVS) at the 67th Vascular Annual Meeting® on May 30, 2013. At Boston Medical Center he is the chief of the Division of Vascular and Endovascular Surgery, medical director of the Catheterization and Angiography Laboratories, and co-director of the Vascular Noninvasive Laboratory. He is an associate professor of surgery and radiology at the Boston University School of Medicine.
Dr. Farber graduated from Brown University with a degree in biology. He obtained his medical degree from Harvard Medical School and finished a residency in general surgery at the Massachusetts General Hospital. He completed his vascular surgery fellowship at Dartmouth and an endovascular surgery fellowship at the Southern Illinois School of Medicine. He has served as a principal investigator in a number of clinical trials and is a principal investigator of the Best Surgery versus Endovascular Therapy (BEST) clinical trial which will compare vascular surgery and endovascular therapy in patients with critical limb ischemia. BEST has been approved by the National Institutes of Health but is still awaiting funding.
He has written and published many articles about vascular and endovascular surgery; has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, Calif. which resulted in the Golden Apple Teaching Award for teaching and mentoring residents.
Ever since his arrival at Boston Medical Center, eight years ago, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. Dr. Farber is a director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgery for their internship.
Dr. Farber is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He has been a leader in many national and regional medical and surgical societies including SVS, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery.
About the Society for Vascular Surgery®
The Society for Vascular Surgery® (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health through education, advocacy, research, and public awareness. SVS is the national advocate for 4,600 specialty-trained vascular surgeons and other medical professionals who are dedicated to the prevention and cure of vascular disease. Visit its website at www.VascularWeb.org®
Susan Walsh, DPM, Division of Podiatry (Foot Care Specialists) at Boston Medical Center and BU School of Medicine has been elected to a two-year term as President of the Massachusetts Podiatric Medical Society (MPMS).
MPMS is the Commonwealth’s professional society for podiatric physicians and surgeons and is the state chapter of the American Podiatric Medical Association.
Boston Medical Center Chief of Surgery Elected President of American Association of Endocrine Surgeons
Gerard Doherty, MD, chief of Surgery at Boston Medical Center (BMC) and chair of the Department of Surgery at Boston University School of Medicine (BUSM) has been elected as President of the American Association of Endocrine Surgeon (AAES). He will serve as President-Elect through 2014 and as President through 2015.
As president, Doherty will preside at council assemblies and the annual members’ assembly. He will appoint members to all committees, serve as an ex-officio member of each, appoint successors to open positions, and deliver the 2015 Presidential Address.
Endocrine surgery is the discipline of surgical management of endocrine disorders, including the understanding of the disease process, and comprehensive care of surgical endocrine disease of the neck and abdomen. The AAES is dedicated to the science and art of endocrine surgery, and maintenance of the highest standards in clinical practice.
“Being chosen by my colleagues to fulfill this role is a distinct honor. The AAES has been my professional home throughout my career, and I admire the many achievements that we have made as a group to improve the care of patients, to advance the field, and to train the next generation of practitioners.”
Doherty’s clinical focus is endocrine oncology and comprises surgical diseases of the thyroid, parathyroid, endocrine pancreas and adrenal glands, as well as the surgical management of multiple endocrine neoplasia (MEN) syndromes.
Prior to coming to Boston Medical Center and Boston University in 2012, Doherty spent a decade as chief of General Surgery at the University of Michigan Health System. He is the immediate past-president of the Michigan Chapter of the American College of Surgeons and has held multiple leadership positions in national and international professional groups, including the Board of Directors of the American Thyroid Association.
A graduate of Holy Cross and Yale School of Medicine, Doherty completed his residency at the UC-San Francisco, including Medical Staff Fellowship at the National Cancer Institute. He joined the faculty at Washington University School of Medicine in 1993 and became professor of Surgery there in 2001.
About the Association of Endocrine Surgeons
The American Association of Endocrine Surgeons (AAES) is dedicated to the advancement of the science and art of endocrine surgery. Our members have clinical expertise in and research interests that focus on endocrine surgical diseases. They are certified by either the American Board of Surgery of the United States, the Royal College of Surgeons of Canada or the equivalent governing boards in Mexico and South America. Our membership has recently expanded to include international leaders in endocrine surgery and allied specialists that have demonstrated a similar focus of practice. The AAES is committed to providing surgical expertise in diseases of the thyroid, parathyroid, adrenal glands as well as in neuroendocrine tumors of the pancreas and GI tract. Our goal is to discover and promote the best treatments for endocrine disease to help improve our patients’ lives.
About Boston Medical Center
Boston Medical Center is a private, not-for-profit, 496-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. Committed to providing high-quality health care to all, the hospital offers a full spectrum of pediatric and adult care services including primary and family medicine and advanced specialty care with an emphasis on community-based care. Boston Medical Center offers specialized care for complex health problems and is a leading research institution. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet – 14 community health centers
For More Information, Contact:
Office of Communications
BMC’s Trauma Centers Receive Reverification for Three Years
(Boston) – May 3, 2013 – The trauma center at Boston Medical Center (BMC) has been re-verified for three years as a Level l Adult Trauma Center and Level II Pediatric Trauma Center by the Verification Review Committee (VRC), an ad hoc committee of the Committee on Trauma (COT) of the American College of Surgeons (ACS).
BMC is the busiest provider of trauma and emergency services in New England, with more than 130,000 emergency visits and approximately 2,000 trauma admissions per year on the same campus. Staffed with seven full-time, dedicated trauma and critical care attending surgeons, the BMC trauma center is the longest continuously verified Level I trauma center in New England.
Established by the American College of Surgeons in 1987, the COT’s Consultation/Verification Program promotes the development of trauma systems. Participant hospitals must demonstrate the resources necessary for the entire spectrum of trauma care to address the needs of all injured patients. This spectrum encompasses the pre-hospital phase through the rehabilitation process.
Trauma centers must meet the required established in the Resources for Optimal Care of the Injured Patient manual. The ACS Committee on Trauma’s verification program does not designate trauma centers. The Massachusetts Department of Public Health is the agency that designates all trauma centers and has made ACS verification (along with other criteria) a requirement.
“Very few hospital programs undergo the level of scrutiny that occurs with a trauma center survey and our success is a testament to all the disciplines and specialties that work with our trauma patients. It is truly an institutional accomplishment,” said Peter Burke, MD, chief of trauma services at BMC.
About the American College of Surgeons
The American College of Surgeons is a scientific and educational association of surgeons that was founded in 1913 to raise the standards of surgical education and practice and to improve the care of the surgical patient. The College has over 72,000 members and it is the largest association of surgeons in the world. Longstanding achievements have placed the ACS in the forefront of American surgery and have made it an important advocate for all surgical patients.
4/17/13 – BU Today: Eyewitness to Terror
Physicians at Boston Medical Center (BMC) are among the first in the city to offer a new treatment option for gastroesophageal reflux disease (GERD), in which a small implanted device is placed around the esophagus to help support a weak lower esophageal sphincter (LES). BMC is one of only two hospitals in New England currently offering the procedure using the LINX® Reflux Management System, which is available in less than 20 hospitals across the country. Click here to read the complete press release
Advanced monitoring during surgery to remove thyroid cancer helped avoid risks to Laurie’s vocal nerve
As a mother of three young children with a busy academic career at Emmanuel College, Laurie Johnston, PhD, was blindsided when her doctor discovered a lump in her neck during a routine physical in July 2012. Within a week, she underwent a thyroid ultrasound and biopsy, which confirmed her doctor’s suspicion of thyroid cancer.
Although she barely had time to comprehend the gravity of her diagnosis, Laurie was determined to find the best care team available for her case. She contacted Gerard Doherty, MD, chief of surgery at Boston Medical Center, on the recommendation of her sister-in-law,
who works in the medical field.
Tony E. Godfrey, PhD, Associate Chair, Surgical Research and Associate Professor of Surgery, Boston University School of Medicine, earned a bachelor’s of science degree in biochemistry from Brunel University in England, followed by a doctorate in molecular biology and biochemistry, also from Brunel. He attended the University of California, San Francisco, for postdoctoral fellowships and managed UCSF’s Genome Analysis Core Facility.
Most recently, Dr. Godfrey was a Research Associate Professor in the Department of Surgery at the University of Rochester Medical Center in Rochester, NY. Prior to this he was an Associate Professor of Pathology at Mt. Sinai School of Medicine in New York, NY.
Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s esophagus and esophageal adenocarcinoma; a tumor with rapidly increasing incidence in the United States and other western countries. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.
Virginia R. Litle, MD
Division of Thoracic Surgery
Associate Professor of Surgery, Boston University School of Medicine
Virginia Litle, MD, Associate Professor of Surgery, Boston University School of Medicine, is a graduate of the University of Vermont in Burlington, VT and received her medical degree from the Brown-Dartmouth Program in Medicine in Providence, RI. Dr. Litle completed her residency in general surgery at the University of California in San Francisco, CA and completed fellowships in both Surgical Oncology and Cardiothoracic Surgery at the University of Pittsburgh Medical Center in Pittsburgh, PA.
Most recently, Dr. Litle was an Associate Professor of Surgery at the University of Rochester Medical Center in Rochester, NY. At BMC/BUSM, Dr. Litle will be Director of the Barrett’s Esophagus Program and Director of Thoracic Clinical Research.
Dr. Litle’s clinical interests include management of benign and malignant esophageal diseases including Barrett’s esophagus, achalasia and esophageal cancer, minimally invasive esophageal surgery and endoscopic procedures including minimally invasive esophagectomy, endoscopic resection and Barrx ablation of Barrett’s esophagus. Dr. Litle also offers VATS lobectomy for lung cancer, airway and esophageal stenting and laser treatment for palliation of lung and esophagus cancer.